Skip to main content
. 2022 May 3;10:815480. doi: 10.3389/fcell.2022.815480

TABLE 3.

Basic clinical characteristics of KIRP patients in validation cohort.

Characteristic Levels Overall
n 30
Pathologic T stage, n (%) T1 21 (70%)
T2 3 (10%)
T3 3 (10%)
T4 3 (10%)
Pathologic N stage, n (%) N0 18 (60%)
N1 9 (30%)
N2 3 (10%)
Pathologic M stage, n (%) M0 27 (90%)
M1 3 (10%)
Pathologic stage, n (%) Stage I 18 (60%)
Stage II 3 (10%)
Stage III 6 (20%)
Stage IV 3 (10%)
Gender, n (%) Female 9 (30%)
Male 21 (70%)
Age, n (%) <=60 15 (50%)
>60 15 (50%)
Age, median (IQR) 62 (55, 70)